Cargando…
Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
INTRODUCTION: Fibroblast growth factor 23 (FGF23), a potential biomarker for kidney function, is related to cardiovascular disease (CVD) and diabetes, although it is unclear whether the relation is causal. This study evaluated the associations of genetically predicted FGF23 with major CVDs, their ri...
Autores principales: | Liang, Ying, Luo, Shan, Schooling, C. Mary, Au Yeung, Shiu Lun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343174/ https://www.ncbi.nlm.nih.gov/pubmed/34367258 http://dx.doi.org/10.3389/fgene.2021.699455 |
Ejemplares similares
-
Corrigendum: Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
por: Liang, Ying, et al.
Publicado: (2021) -
Associations of Arachidonic Acid Synthesis with Cardiovascular Risk Factors and Relation to Ischemic Heart Disease and Stroke: A Univariable and Multivariable Mendelian Randomization Study
por: Zhang, Ting, et al.
Publicado: (2021) -
Association of genetically predicted blood sucrose with coronary heart disease and its risk factors in Mendelian randomization
por: Zhang, Ting, et al.
Publicado: (2020) -
Use of Multivariable Mendelian Randomization to Address Biases Due to Competing Risk Before Recruitment
por: Schooling, C. M., et al.
Publicado: (2021) -
Vascular Endothelial Growth Factor and Ischemic Heart Disease Risk: A Mendelian Randomization Study
por: Au Yeung, Shiu Lun, et al.
Publicado: (2017)